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Dear Editor,
Eczema is an inflammatory dermatitis mediated 
by cellular immunity, with an etiology in which envi-
ronmental, immunological, and genetic factors are in-
volved. Skin inflammation through proinflammatory 
cytokines creates a favorable environment for micro-
bial antigens and optimal conditions for infection (1). 
In case of underlying immunosuppression, inflamma-
tory features of dermatitis and superimposed infec-
tions are more severe. The presence of minor trauma 
of the skin in the form of fissures can favor both easier 
inoculation of some bacterial germs, leading to a der-
matitis superinfection, and/or the transcutaneous in-
oculation of atypical mycobacteria, with a possibility 
of developing localized types of tuberculous lymph-
adenitis (TLA). TLA, the localized type of systemic tu-
berculosis (TB) infection, is the most common form 
of extra-pulmonary TB in developing countries (2), 
while lymphadenitis due to atypical mycobacteria is 
a localized disease, more frequently seen in devel-
oped countries (3,4). In tuberculosis, the transmission 
of Mycobacterium tuberculosis is airborne, while in 
atypical mycobacterium lymphadenitis transmission 
can be both airborne or by ingestion or inoculation 
(5). In both forms of TB, lymphadenopathy evolves to-
wards abscess and presents fibrotic scars or calcifica-
tions upon healing (6). A positive diagnosis involves a 
clinical and epidemiological investigation, a purified 
protein derivative (PPD) skin test, ultrasound, and CT 
/ MRI of lymph node masses. A lymph node biopsy is 
used to confirm the diagnosis of TB and PCR, while 
positive culture confirms the etiology of TB lymph-
adenitis. The differential diagnosis of TLA is difficult: 
neoplastic, bacterial, or viral and fungal infections, 
sarcoidosis, Castleman’s disease, drug reactions, 
etc. (5). TB-induced immunosuppression may favor 
the development of fungal and bacterial infections, 
sometimes severe and poorly responsive to treat-
ment. On the other hand, immunosuppressive condi-
tions increase the risk of extra-pulmonary TB (2).
A 40-year old woman who had experienced re-
current episodes of dermatitis over the previous 7 
years was hospitalized with fever, malaise, and a dis-
seminated erythematous and crusted, exudative, and 
flexural itching rash (Figure 1). There were fetid, puru-
lent secretions at the conjunctival, auricular, genital, 
and umbilical areas. The clinical exam also revealed 
lymphadenopathy syndrome (large, painful subman-
dibular, cervical, and axillar bilateral lymph nodes; an 
indurated, painful, and adherent left inguinal lymph 
node of 5-6 cm).
Figure 2. Histopathological features of tuberculous lymph-
adenitis (hematoxylin and eosin ×100).
Figure 1. Clinical manifestations of the skin lesions on the 
groin and perineum at first referral. 
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Microbial cultures isolated multiple multi-drug-
resistant bacteria (SAH-MRSA, Acinetobacter bauman-
nii, Enterococcus faecalis, E. coli, Enterobacter) and 
Candida albicans in the oral cavity and conjunctival, 
auricular, nasal, umbilical, and genital areas. The skin 
biopsy confirmed the diagnosis of dermatitis. PPD 
skin test was 21 mm. Other tests (HIV and syphilis se-
rology, blood culture, chest X-ray) were negative.
Systemic treatment with vancomycin, metroni-
dazole, fluconazole, local antiseptic compresses, and 
topical corticosteroid ointments was initiated. 2 days 
after starting the treatment with vancomycin, Red-
man syndrome occurred (headache, dyspnea, colicky 
pains, myalgia, rush, fever (39 °C), hypotension (80/40 
mmHg), and tachycardia (100 bpm)). This syndrome 
resolved upon discontinuation of Vancomycin. Fur-
ther treatment with imipenem/cilastatinand linezolid 
for 14 days lead to a favorable response with amelio-
ration of the symptoms.
Biopsy of the submandibular lymph node raised 
the suspicion of Castleman’s disease; however, due 
to the overall incomplete clinical picture (no night 
sweats, no weight reduction, lack of hepatospleno-
megaly and peripheral neuropathy), we decided to 
perform a biopsy of an inguinal lymph node. The his-
topathological aspect suggested TLA (lymphoid hy-
perplasia predominantly diffuse, reactive, presenting 
tuberculous follicles with central caseous necrosis) 
(Figure 2).
A combination of specific antituberculous drugs 
(isoniazid, rifampicin, pyrazinamide, and ethambu-
tol) for 6 months resolved the lymphadenopathy syn-
drome with no further recurrence of eczema and skin 
infections.
Certain delayed hypersensitivity mechanisms are 
involved both in dermatitis and in TB. CD4 lympho-
cytes are the primary mediators of anti-TB immunity, 
while proinflammatory cytokines mediate the activa-
tion of macrophages involved in controlling bacillary 
growth (1). In cases of superinfected dermatitis, mi-
crobial exotoxins penetrate the skin barrier more eas-
ily due to inflammation. Released cytokines (IL-1, TNF, 
and IL12) favor the expression of E-selectin on endo-
thelial vascular growth factor and on skin lymphocyte 
antigen expression, with amplification of initial skin 
inflammation and creating favorable conditions for 
microbial colonization and infection (7). The common 
denominator in dermatitis and TB are the circulating 
immune complexes (up to 56% of TB cases), which 
are formed by the interaction between an antibody 
and bacterial antigen (8), which was in this case evi-
denced by increased levels of IgA and IgG.
In our case, the frequent recurrences of infected 
dermatitis with multiple multi-drug-resistant germs 
that were poorly responsive to treatment and dis-
played a severe evolution towards generalization as 
well as the lymphadenopathy and the persistence of a 
biological inflammatory syndrome indicated that an-
other immunosuppressive cause could be involved. 
Isolated bacterial and fungal germs changed the im-
mune status of the patient. The risk of mycobacterium 
infection was increased by the environment they cre-
ated and the patient’s underlying skin inflammation. 
The diagnosis of TB lymphadenitis was established 
by the histopathologist, but in the absence of PCR we 
could not determine whether the TB infection was 
caused by Mycobacterium tuberculosis or by atypical 
mycobacteria. Given that there was no evidence of 
other sites of TB infection, we conjectured that inocu-
lation of mycobacterium took place at the skin lesion 
and that an atypical mycobacterium might have con-
tributed to the etiology of the TLA. In our case, the 
anti-tuberculous drugs and skin infection treatment 
with follow-up of the side-effects led to complete re-
mission of mycobacterium lymphadenitis, dermatitis, 
and infectious processes, without relapses.
In conclusion, in the present case chronic der-
matitis alongside infection with multi-drug-resistant 
germs led to an immunosuppressive status which, 
when associated with the presence of multiple skin 
ports of entry, allowed a mycobacterial infection at 
the inguinal lymph node level. Inguinal TLA induced 
severe dermatitis and difficulties in diagnosis and 
treatment.
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